CytoMed Therapeutics Pte Ltd 新细胞医学 is rated 3 out of 5 in the category biotechnology. Read and write reviews about CytoMed Therapeutics Pte Ltd 新细胞医学. Incorporated in 2018, CytoMed Therapeutics is a spin-off from Singapore’s Agency for Science, Technology and Research ( A*Star) and focuses on translating its patented technologies into gamma delta (γδ) T cell- and natural killer (NK) cell-based “off-the-shelf” immunotherapeutics for a wide range of cancers. We also engage in generating induced pluripotent stem cells (iPSCs) and translating them into “off-the-shelf” cellular therapeutics using our proprietary technologies for our customers.
Address
31 Biopolis Way, The Nanos #04-55
Company size
11-50 employees
Headquarters
Singapore, Singapore